Table 1 Clinical information and its association with AA metabolism in the TCGA-BRCA cohort
From: The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics
Characteristics | Low (N = 546) | High (N = 545) | Total (N = 1091) | P-value |
|---|---|---|---|---|
Age | Â | Â | Â | 0.20 |
 < 60 | 301 (27.61%) | 278 (25.50%) | 579 (53.12%) |  |
 ≥ 60 | 245 (22.48%) | 266 (24.40%) | 511 (46.88%) |  |
Pam50 | Â | Â | Â | 3.9e-25 |
 Normal | 6 (0.55%) | 34 (3.12%) | 40 (3.67%) |  |
 LumA | 213 (19.52%) | 351 (32.17%) | 564 (51.70%) |  |
 LumB | 151 (13.84%) | 64 (5.87%) | 215 (19.71%) |  |
 Basal | 134 (12.28%) | 56 (5.13%) | 190 (17.42%) |  |
 Her2 | 42 (3.85%) | 40 (3.67%) | 82 (7.52%) |  |
Stage | Â | Â | Â | 0.16 |
 I/II | 407 (38.14%) | 393 (36.83%) | 800 (74.98%) |  |
 III/IV | 124 (11.62%) | 143 (13.40%) | 267 (25.02%) |  |